Mehmet Fatih Senturk1, Emre Cimen2, Aysegul Mine Tuzuner Oncul3, Mine Cambazoglu3. 1. Dentistry Faculty, Oral and Maxillofacial Surgery Department, Suleyman Demirel University, Isparta, Turkey. 2. Dentistry, Oral and Maxillofacial Surgery, Ugurel Dental Clinic, Istanbul, Turkey. 3. Dentistry Faculty, Oral and Maxillofacial Surgery Department, Ankara University, Ankara, Turkey.
Abstract
OBJECTIVE: To evaluate the oncologists thoughts about the positive and adverse effects of bisphosphonates, drug holiday and the awareness about BRONJ. METHODS: A written questionnaire was sent to 7 hospitals, which have oncology facilities in Ankara, Turkey. Results were evaluated as percentages. Chi Square and Kruskal Wallis H test was used to analyze the data. RESULTS: A total of 53 oncologists replied to the questionnaire. BRONJ is the most seen complication (66%) due to bisphosphonates usage. Temporary suspension of the drug (52.8%) is the best treatment choice for this complication. Oncologists usually prefered dentist consultatation (39.6%). CONCLUSIONS: A good cooperation of oncologists and dentists is very important to prevent BRONJ.
OBJECTIVE: To evaluate the oncologists thoughts about the positive and adverse effects of bisphosphonates, drug holiday and the awareness about BRONJ. METHODS: A written questionnaire was sent to 7 hospitals, which have oncology facilities in Ankara, Turkey. Results were evaluated as percentages. Chi Square and Kruskal Wallis H test was used to analyze the data. RESULTS: A total of 53 oncologists replied to the questionnaire. BRONJ is the most seen complication (66%) due to bisphosphonates usage. Temporary suspension of the drug (52.8%) is the best treatment choice for this complication. Oncologists usually prefered dentist consultatation (39.6%). CONCLUSIONS: A good cooperation of oncologists and dentists is very important to prevent BRONJ.
Entities:
Keywords:
Bisphosphonates related osteonecrosis of the jaw (BRONJ), oncologists, questionnaire.
Authors: Wanessa Miranda-Silva; Marco Aurélio Montezuma; Bernar Monteiro Benites; Julia Stephanie Bruno; Felipe Paiva Fonseca; Eduardo Rodrigues Fregnani Journal: Support Care Cancer Date: 2020-03-06 Impact factor: 3.603